BIOMAT Database Logo BIOMAT Database Logo

Hypotensive sequelae of diazoxide and hydralazine therapy. 1977

W L Henrich, and R Cronin, and P D Miller, and R J Anderson

UI MeSH Term Description Entries
D007022 Hypotension Abnormally low BLOOD PRESSURE that can result in inadequate blood flow to the brain and other vital organs. Common symptom is DIZZINESS but greater negative impacts on the body occur when there is prolonged depravation of oxygen and nutrients. Blood Pressure, Low,Hypotension, Vascular,Low Blood Pressure,Vascular Hypotension
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D003981 Diazoxide A benzothiadiazine derivative that is a peripheral vasodilator used for hypertensive emergencies. It lacks diuretic effect, apparently because it lacks a sulfonamide group. Hyperstat,Proglycem
D004357 Drug Synergism The action of a drug in promoting or enhancing the effectiveness of another drug. Drug Potentiation,Drug Augmentation,Augmentation, Drug,Augmentations, Drug,Drug Augmentations,Drug Potentiations,Drug Synergisms,Potentiation, Drug,Potentiations, Drug,Synergism, Drug,Synergisms, Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006830 Hydralazine A direct-acting vasodilator that is used as an antihypertensive agent. Hydrallazin,Apresoline,Apressin,Apressoline,Hydralazine Hydrochloride,Hydralazine mono-Hydrochloride,Hydrazinophthalazine,Nepresol,Hydralazine mono Hydrochloride,Hydrochloride, Hydralazine,mono-Hydrochloride, Hydralazine
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

W L Henrich, and R Cronin, and P D Miller, and R J Anderson
Hypotensive sequelae of diazoxide and hydralazine therapy.
September 1977, JAMA,
W L Henrich, and R Cronin, and P D Miller, and R J Anderson
Hypotension and bradycardia following diazoxide and hydralazine therapy.
June 1977, JAMA,
W L Henrich, and R Cronin, and P D Miller, and R J Anderson
Hypotensive action of diazoxide.
March 1973, Lancet (London, England),
W L Henrich, and R Cronin, and P D Miller, and R J Anderson
Myocardial inactivity of therapeutic concentrations of hydralazine and diazoxide.
February 1974, Experientia,
W L Henrich, and R Cronin, and P D Miller, and R J Anderson
Indomethacin attenuates the hypotensive action of hydralazine.
May 1986, Clinical pharmacology and therapeutics,
W L Henrich, and R Cronin, and P D Miller, and R J Anderson
Systemic vasodilatation and renal sodium excretion: effects of hydralazine and diazoxide.
May 1984, Life sciences,
W L Henrich, and R Cronin, and P D Miller, and R J Anderson
[Central origin of the hypotensive action of hydralazine].
May 1955, Comptes rendus hebdomadaires des seances de l'Academie des sciences,
W L Henrich, and R Cronin, and P D Miller, and R J Anderson
Hypotensive and renal effects of diazoxide, a sodiumretaining benzothiadiazine compound.
May 1963, Circulation,
W L Henrich, and R Cronin, and P D Miller, and R J Anderson
Diazoxide: influence of speed of injection on hypotensive response.
April 1979, The Medical journal of Australia,
W L Henrich, and R Cronin, and P D Miller, and R J Anderson
Relation of hydralazine plasma concentration to dosage and hypotensive action.
January 1972, Clinical pharmacology and therapeutics,
Copied contents to your clipboard!